Mirae Asset Global Investments »

Relmada Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 270k 4.14
2023-09-30 $777k 259k 3.00
2023-06-30 $834k 339k 2.46
2023-03-31 $578k 289k 2.00
2022-12-31 $975k 279k 3.49
2022-09-30 $2.7M 72k 37.33
2022-06-30 $826k 43k 19.01